Stocks
Medicare Advantage Plans: Trump Administration's New Chip in Healthcare Policy
724FinanceCeyda Uyar
The Trump administration's decision to end a program that kept Medicare prescription drug costs lower could boost Medicare Advantage plan enrollments. This move risks making plans more attractive as drug prices rise, potentially increasing sign-ups by 20% in 2026. The shift could signal a major transformation in the healthcare insurance sector.